AVITA Medical (AVITA Medical) Additional Paid-In Capital : $350.04 Mil(As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is AVITA Medical Additional Paid-In Capital?

AVITA Medical's quarterly additional paid-in capital increased from Jun. 2023 ($343.77 Mil) to Sep. 2023 ($347.19 Mil) and increased from Sep. 2023 ($347.19 Mil) to Dec. 2023 ($350.04 Mil).

AVITA Medical's annual additional paid-in capital increased from Jun. 2021 ($328.89 Mil) to Dec. 2022 ($339.83 Mil) and increased from Dec. 2022 ($339.83 Mil) to Dec. 2023 ($350.04 Mil).

AVITA Medical Additional Paid-In Capital Historical Data

The historical data trend for AVITA Medical's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AVITA Medical Additional Paid-In Capital Chart

AVITA Medical Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Dec22

Dec23

Additional Paid-In Capital

Get a 7-Day Free Trial

165.47

259.17

328.89

339.83

350.04

AVITA Medical Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Additional Paid-In Capital	Get a 7-Day Free Trial															339.83	342.40	343.77	347.19	350.04

AVITA Medical Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

AVITA Medical Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of AVITA Medical's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

AVITA Medical (AVITA Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AVITA Medical Inc (OTCPK:AVHHL) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

RCEL:USA 51KB:Germany AVH:Australia

Address

28159 Avenue Stanford, Suite 220, Valencia, Los Angeles, CA, USA, 91355

Website

https://www.avitamedical.com

Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the U.S. with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 U.S. burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the U.S. region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the U.S.